HERB OTC
Humanoid Inc
1W: +100.0%
1M: +29.8%
3M: +14.5%
YTD: -25.9%
1Y: -32.0%
3Y: -73.6%
5Y: -56.4%
$0.02
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$24M
+14.2% ▲
5Y CAGR: +22.7%
Gross Profit
$8M
+14.7% ▲
5Y CAGR: +45.9%
Operating Income
$7M
+15.0% ▲
5Y CAGR: +56.0%
Net Income
$8M
+15.0% ▲
5Y CAGR: +51.5%
EPS (Diluted)
$0.05
+15.0% ▲
5Y CAGR: +54.1%
EBITDA
$8M
+3.3% ▲
5Y CAGR: +42.8%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $13M | $14M | $19M | $21M | $24M |
| YoY Growth | +44.6% | +11.7% | +32.6% | +13.7% | +14.2% |
| Cost of Revenue | $9M | $10M | $13M | $14M | $16M |
| Gross Profit | $3M | $4M | $6M | $7M | $8M |
| Gross Margin | 25.8% | 28.6% | 30.1% | 33.3% | 33.5% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $500K | $555K | $677K | $780K | $880K |
| Operating Expenses | $500K | $555K | $677K | $780K | $880K |
| Operating Income | $3M | $3M | $5M | $6M | $7M |
| Operating Margin | 21.8% | 24.7% | 26.4% | 29.6% | 29.8% |
| Interest Expense | $2K | $2K | $3K | $5K | $0 |
| Income Before Tax | $3M | $4M | $5M | $7M | $8M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | $3M | $4M | $5M | $7M | $8M |
| Net Margin | 23.8% | 26.5% | 28.6% | 33.2% | 33.4% |
| EPS (Diluted) | $0.02 | $0.02 | $0.03 | $0.04 | $0.05 |
| EBITDA | $3M | $4M | $5M | $7M | $8M |
| Shares Outstanding | 173M | 173M | 157M | 157M | 157M |